"Never Seen Anything Like It:" The Biggest Month in Antitrust in 50 Years
The changeover has been absolutely stark, and it’s accelerating. Many of my sources in the competition policy world are giving me the same message, which is that this is the most extraordinary month they have ever seen in antitrust.
There are the big fights, the cases against Google and Amazon, the suits against private equity and meat... See more
There are the big fights, the cases against Google and Amazon, the suits against private equity and meat... See more
Matt Stoller • "Never Seen Anything Like It:" The Biggest Month in Antitrust in 50 Years
How the feds cracked the biggest health-care-fraud scheme in U.S. history - The Washington Post
Inside Operation Gold Rush, largest health care fraud bust in U.S. history — The Washington Post
Between 2006 and 2019, 9 out of 10 FDA commissioners went on to work for the pharmaceutical companies they were in charge of regulating.
Approximately 65% of the FDA's drug review budget comes directly from the pharmaceutical industry.
Americans are the sickest people on the planet, and our... See more
The number of pay-for-delay arrangements has increased dramatically since 2010, and the result is no generic drug competition to produce cheaper alternative versions for a growing number of brand-name drugs. The Federal Trade Commission (FTC) says these anticompetitive agreements cost consumers and taxpayers $3.5 billion in higher drug costs every
... See moreElisabeth Rosenthal • An American Sickness: How Healthcare Became Big Business and How You Can Take It Back
